Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.263
+0.004 (1.55%)
At close: Nov 4, 2024, 4:00 PM
0.256
-0.007 (-2.62%)
Pre-market: Nov 5, 2024, 5:32 AM EST
Lyra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 17 | 275 | 100 | 57 | 147 | - | |
| Market Cap Growth | -91.71% | 175.60% | 76.26% | -61.52% | - | - | |
| Enterprise Value | -14 | 179 | -9 | 0 | 68 | - | |
| Last Close Price | 0.26 | 5.24 | 3.14 | 4.36 | 11.40 | - | |
| PE Ratio | - | -4.16 | -1.72 | -1.30 | -4.40 | - | |
| PS Ratio | 8.96 | 176.78 | 73.32 | 198.95 | - | - | |
| PB Ratio | 0.56 | 3.08 | 1.24 | 1.65 | 1.98 | - | |
| P/FCF Ratio | -0.21 | -4.28 | -2.29 | -1.94 | -6.43 | - | |
| P/OCF Ratio | -0.22 | -4.35 | -2.30 | -2.20 | -6.97 | - | |
| EV/Sales Ratio | -17.80 | 115.00 | -6.58 | 0.97 | - | - | |
| EV/EBITDA Ratio | 0.44 | -2.75 | 0.17 | -0.01 | -3.10 | - | |
| EV/EBIT Ratio | 0.43 | -2.73 | 0.16 | -0.01 | -3.08 | - | |
| EV/FCF Ratio | 0.41 | -2.78 | 0.21 | -0.01 | -2.99 | - | |
| Debt / Equity Ratio | 1.19 | 0.30 | 0.03 | 0.04 | 0.03 | 0.45 | |
| Debt / FCF Ratio | -0.47 | -0.42 | -0.05 | -0.05 | -0.11 | -0.24 | |
| Asset Turnover | 0.02 | 0.01 | 0.02 | 0.00 | - | - | |
| Quick Ratio | 3.50 | 5.24 | 6.77 | 2.51 | 15.27 | 1.88 | |
| Current Ratio | 3.60 | 5.35 | 6.97 | 2.63 | 15.54 | 1.94 | |
| Return on Equity (ROE) | -156.52% | -73.67% | -96.08% | -79.98% | -54.09% | -106.55% | |
| Return on Assets (ROA) | -42.36% | -32.43% | -41.70% | -40.18% | -28.98% | -51.21% | |
| Return on Capital (ROIC) | -55.53% | -41.10% | -57.89% | -48.38% | -31.70% | -60.85% | |
| Earnings Yield | -589.18% | -22.76% | -55.31% | -76.74% | -15.01% | - | |
| FCF Yield | -458.40% | -23.36% | -43.58% | -51.51% | -15.55% | - | |
| Buyback Yield / Dilution | -60.70% | -64.72% | -132.83% | -51.17% | -4150.62% | -21.66% | |
| Total Shareholder Return | -60.70% | -64.72% | -132.83% | -51.17% | -4150.62% | -21.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.